CT
CeleCor Therapeutics, Inc.
SEC filingPharmaceuticals · Del Mar, CA
Amount raised$11.9Msold at filing
Total offering$15M$3.1M still open
Investors in the raise17count reported to the SEC
FiledJul 9, 2026first sale Jun 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Robert S. Hillman, Ph.D.Executive Officer, Director
Peter B. FinnExecutive Officer
Jack S. LiefDirector
Andreas S. RitziDirector
Executive officers, directors and promoters as listed on the Form D.